Pasithea Therapeutics Corp Stock Market Value
| KTTAW Stock | USD 0.02 0.0003 1.50% |
| Symbol | Pasithea |
Pasithea Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pasithea Therapeutics. If investors know Pasithea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pasithea Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.37 | Return On Assets (0.38) | Return On Equity (0.63) |
The market value of Pasithea Therapeutics is measured differently than its book value, which is the value of Pasithea that is recorded on the company's balance sheet. Investors also form their own opinion of Pasithea Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Pasithea Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pasithea Therapeutics' market value can be influenced by many factors that don't directly affect Pasithea Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pasithea Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pasithea Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pasithea Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Pasithea Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pasithea Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pasithea Therapeutics.
| 10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in Pasithea Therapeutics on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Pasithea Therapeutics Corp or generate 0.0% return on investment in Pasithea Therapeutics over 30 days. Pasithea Therapeutics is related to or competes with Eliem Therapeutics, HCW Biologics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric an... More
Pasithea Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pasithea Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pasithea Therapeutics Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 25.96 | |||
| Information Ratio | 0.1958 | |||
| Maximum Drawdown | 141.61 | |||
| Value At Risk | (31.89) | |||
| Potential Upside | 61.29 |
Pasithea Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pasithea Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pasithea Therapeutics' standard deviation. In reality, there are many statistical measures that can use Pasithea Therapeutics historical prices to predict the future Pasithea Therapeutics' volatility.| Risk Adjusted Performance | 0.1633 | |||
| Jensen Alpha | 5.45 | |||
| Total Risk Alpha | 1.23 | |||
| Sortino Ratio | 0.2188 | |||
| Treynor Ratio | 1.97 |
Pasithea Therapeutics Backtested Returns
Pasithea Therapeutics is out of control given 3 months investment horizon. Pasithea Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.18, which implies the firm had a 0.18% return per unit of risk over the last 3 months. We were able to analyze twenty-eight different technical indicators, which can help you to evaluate if expected returns of 32.61% are justified by taking the suggested risk. Use Pasithea Therapeutics Coefficient Of Variation of 499.3, semi deviation of 16.91, and Risk Adjusted Performance of 0.1633 to evaluate company specific risk that cannot be diversified away. Pasithea Therapeutics holds a performance score of 14 on a scale of zero to a hundred. The company holds a Beta of 2.95, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Pasithea Therapeutics will likely underperform. Use Pasithea Therapeutics total risk alpha, downside variance, as well as the relationship between the Downside Variance and rate of daily change , to analyze future returns on Pasithea Therapeutics.
Auto-correlation | 0.44 |
Average predictability
Pasithea Therapeutics Corp has average predictability. Overlapping area represents the amount of predictability between Pasithea Therapeutics time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pasithea Therapeutics price movement. The serial correlation of 0.44 indicates that just about 44.0% of current Pasithea Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.44 | |
| Spearman Rank Test | -0.6 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Pasithea Therapeutics lagged returns against current returns
Autocorrelation, which is Pasithea Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pasithea Therapeutics' stock expected returns. We can calculate the autocorrelation of Pasithea Therapeutics returns to help us make a trade decision. For example, suppose you find that Pasithea Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pasithea Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pasithea Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pasithea Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pasithea Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Pasithea Therapeutics Lagged Returns
When evaluating Pasithea Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pasithea Therapeutics stock have on its future price. Pasithea Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pasithea Therapeutics autocorrelation shows the relationship between Pasithea Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Pasithea Therapeutics Corp.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Pasithea Stock Analysis
When running Pasithea Therapeutics' price analysis, check to measure Pasithea Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pasithea Therapeutics is operating at the current time. Most of Pasithea Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pasithea Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pasithea Therapeutics' price. Additionally, you may evaluate how the addition of Pasithea Therapeutics to your portfolios can decrease your overall portfolio volatility.